CMS Statement on Proposed Local Coverage Determination (LCD) for Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers

CMS Announces Proposed Coverage for Skin Substitute Grafts

On April 25, 2024, the Medicare Administrative Contractors (MACs) released a proposed Local Coverage Determination (LCD) aimed at providing appropriate coverage for skin substitute grafts used in the treatment of chronic non-healing diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). This collaborative effort, titled "Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers," ensures that Medicare beneficiaries have access to skin substitute products supported by evidence as reasonable and necessary for treating these conditions, aligning with professional guidelines for effective wound management.

Call for Public Comments on Coverage Determination for Skin Substitute Grafts

CMS encourages all interested parties to participate in the LCD process by providing comments during the public comment period, which remains open until June 8, 2024. Each MAC will host public listening sessions throughout May, offering additional opportunities for stakeholder engagement on this proposed coverage policy.

CMS Commitment to Access and Engagement

CMS prioritizes ensuring that Medicare beneficiaries have access to clinically appropriate items and services. The organization will closely monitor the LCD process to guarantee meaningful engagement opportunities.

How to Participate

The LCD process is open to all interested parties wishing to submit comments on the proposed determination. To participate:

• Submit comments by June 8, 2024, via your MAC’s website.

• Attend an Open Meeting where the proposed LCD will be discussed. Registration details are available on your MAC’s website or the CMS Landing Page at CMS LCD Process.

• If unable to attend an Open Meeting, recordings will be posted on each MAC’s website.

For more information, visit the CMS LCD Process.

Press Release Details

Date: April 25, 2024Source: CMS News and Media GroupContact: Catherine Howden, DirectorMedia Inquiries: 202-690-6145